ReviewHeliyon2023

Anti-PD-(L)1 therapy of non-small cell lung cancer-A summary of clinical trials and current progresses.

Keywan Mortezaee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.